<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axovant Gene Therapies Ltd.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that address serious neurological and neuromuscular diseases with significant unmet medical needs. We are currently studying gene therapy candidates for GM1 gangliosidosis, Tay-Sachs and Sandhoff diseases, and Parkinson’s disease in clinical trials and are working quickly to bring gene therapy candidates for other indications to patients in the clinic. We know that patients can’t wait, so neither will we. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Pavan Cheruvu, MD
    • FOUNDED
      2014
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Moderna, Inc.

    Moderna, Inc.

    Moderna is advancing messenger RNA (mRNA) science to create a new class of transfo...

    Moderna is advancing messenger RNA (mRNA) scien...

    Filing Type:    PU
    WayBetter, Inc

    WayBetter, Inc

    WayBetter helps motivate people to adopt healthy behaviors through a combination o...

    WayBetter helps motivate people to adopt health...

    Filing Type:    RARD
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Sonoma Pharmaceuticals, Inc.

    Sonoma Pharmaceuticals, Inc.

    Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and mar...

    Sonoma Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Theratechnologies Inc.

    Theratechnologies Inc.

    Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet...

    Theratechnologies (TSX: TH) is a specialty phar...

    Filing Type:    PU
    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...

    Sangamo Therapeutics, Inc. is focused on transl...

    Filing Type:    PU
    uniQure N.V.

    uniQure N.V.

    uniQure is delivering on the promise of gene therapy -- single treatments with pot...

    uniQure is delivering on the promise of gene th...

    Filing Type:    PU
    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc. is using its deep understanding of time-dependent bio...

    Adamas Pharmaceuticals, Inc. is using its deep ...

    Filing Type:    PU
    Quadrant Biosciences Inc

    Quadrant Biosciences Inc

    Quadrant Biosciences is an epigenetic diagnostics company with a focus on the earl...

    Quadrant Biosciences is an epigenetic diagnosti...

    Filing Type:    RA
    Assertio Therapeutics, Inc.

    Assertio Therapeutics, Inc.

    Assertio Therapeutics is committed to providing responsible solutions to advance p...

    Assertio Therapeutics is committed to providing...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.